1. Home
  2. HURA vs LCUT Comparison

HURA vs LCUT Comparison

Compare HURA & LCUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURA
  • LCUT
  • Stock Information
  • Founded
  • HURA 2009
  • LCUT 1945
  • Country
  • HURA United States
  • LCUT United States
  • Employees
  • HURA N/A
  • LCUT N/A
  • Industry
  • HURA
  • LCUT Industrial Machinery/Components
  • Sector
  • HURA
  • LCUT Consumer Discretionary
  • Exchange
  • HURA Nasdaq
  • LCUT Nasdaq
  • Market Cap
  • HURA 96.5M
  • LCUT 111.4M
  • IPO Year
  • HURA N/A
  • LCUT 1991
  • Fundamental
  • Price
  • HURA $3.48
  • LCUT $4.82
  • Analyst Decision
  • HURA Strong Buy
  • LCUT Buy
  • Analyst Count
  • HURA 2
  • LCUT 2
  • Target Price
  • HURA $12.00
  • LCUT $7.50
  • AVG Volume (30 Days)
  • HURA 272.1K
  • LCUT 58.3K
  • Earning Date
  • HURA 05-15-2025
  • LCUT 03-13-2025
  • Dividend Yield
  • HURA N/A
  • LCUT 3.54%
  • EPS Growth
  • HURA N/A
  • LCUT N/A
  • EPS
  • HURA N/A
  • LCUT N/A
  • Revenue
  • HURA N/A
  • LCUT $682,952,000.00
  • Revenue This Year
  • HURA N/A
  • LCUT $2.53
  • Revenue Next Year
  • HURA $221.29
  • LCUT $3.55
  • P/E Ratio
  • HURA N/A
  • LCUT N/A
  • Revenue Growth
  • HURA N/A
  • LCUT N/A
  • 52 Week Low
  • HURA $1.80
  • LCUT $4.70
  • 52 Week High
  • HURA $14.60
  • LCUT $11.68
  • Technical
  • Relative Strength Index (RSI)
  • HURA N/A
  • LCUT 39.78
  • Support Level
  • HURA N/A
  • LCUT $4.98
  • Resistance Level
  • HURA N/A
  • LCUT $5.21
  • Average True Range (ATR)
  • HURA 0.00
  • LCUT 0.29
  • MACD
  • HURA 0.00
  • LCUT -0.04
  • Stochastic Oscillator
  • HURA 0.00
  • LCUT 11.11

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

About LCUT Lifetime Brands Inc.

Lifetime Brands Inc is a U.S. based company that designs, sources, and sells branded kitchenware, tableware, and other products used in the home and markets its products under brands such as Farberware, KitchenAid, Mikasa, and others. The company markets and sells its products principally on a wholesale basis to retailers. It also markets and sells a limited selection of its products directly to consumers through its Pfaltzgraff, Mikasa, Fred, and Friends, Built NY, and others. Its products include kitchen tools, gadgets, cutlery, dinnerware, and glassware. The segments of the company are the U.S. and International. It derives a majority of its revenue from the U.S. segment. The company derives maximum revenue from Kitchenware products.

Share on Social Networks: